Table 2.
Ordinal regression analysis of the influence of clinical phenodata on the favorable functional status (0–2 at mRS) of all patients at discharge and on 90th day of stroke.
| Coefficients | At discharge | At 90th day after MT | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p-value | OR | 95% CI | p-value | |
| Age | 0.957 | (0.938–0.976) | 0.000 | 0.960 | (0.943–0.976) | 0.000 |
| Female sex | 0.614 | (0.388–0.967) | 0.036 | 0.919 | (0.629–1.339) | 0.661 |
| NIHSS1 | 0.853 | (0.813–0.893) | 0.000 | 0.894 | (0.861–0.925) | 0.000 |
| AF | 1.374 | (0.827–2.282) | 0.219 | 1.553 | (1.029–2.359) | 0.037 |
| Arterial hypertension | 1.034 | (0.616–1.754) | 0.900 | 1.379 | (0.893–2.140) | 0.148 |
| DM | 0.505 | (0.286–0.865) | 0.015 | 0.759 | (0.500–1.149) | 0.193 |
| Atherosclerosis | 1.356 | (0.839–2.192) | 0.213 | 0.981 | (0.660–1.461) | 0.926 |
| Smoking | 1.034 | (0.801–1.334) | 0.798 | 0.984 | (0.798–1.213) | 0.879 |
| Dyslipidemia | 1.177 | (0.770–1.792) | 0.448 | 1.034 | (0.733–1.458) | 0.850 |
| IVT | 0.854 | (0.541–1.351) | 0.497 | 1.539 | (1.051–2.262) | 0.027 |
| ICA | 0.996 | (0.230–4.259) | 0.996 | 0.547 | (0.161–1.826) | 0.327 |
| ACA | 0.814 | (0.200–2.712) | 0.752 | 0.595 | (0.210–1.669) | 0.321 |
| MCA | 2.388 | (1.040–5.521) | 0.040 | 1.296 | (0.649–2.616) | 0.465 |
| VA | 0.643 | (0.155–2.404) | 0.524 | 0.497 | (0.154–1.642) | 0.243 |
| BA | 1.555 | (0.486–4.759) | 0.444 | 0.897 | (0.338–2.396) | 0.827 |
| PA | 4.873 | (1.403–16.461) | 0.011 | 1.556 | (0.511–5.055) | 0.444 |
| mTICI 2b–3 | 1.312 | (0.660–1.813) | 0.002 | 0.792 | (0.871–0.921) | 0.002 |
| Time from symptoms to MT | 0.996 | (0.993–0.998) | 0.001 | 0.998 | (0.996–1.000) | 0.114 |
| MT time | 0.986 | (0.980–0.992) | 0.000 | 0.989 | (0.984–0.994) | 0.000 |
| ICH | 0.751 | (0.147–1.513) | 0.022 | 0.312 | (0.311–0.864) | 0.039 |
| DH | 0.217 | (0.210–1.171) | 0.037 | 1.214 | (1.047–2.314) | 0.026 |
mRS modified Rankin Scale, OR odds ratio, CI confidence interval, NIHSS1 National Institutes of Health Stroke Scale on admission, AF atrial fibrillation, DM diabetes mellitus, IVT intravenous thrombolysis, ICA internal carotid artery, ACA anterior cerebral artery, MCA middle cerebral artery, VA vertebral artery, BA basilar artery, PA posterior cerebral artery, mTICI 2b–3 modified Thrombolysis In Cerebral Infarction scale 2b–3, MT mechanical thrombectomy, ICH intracranial haemorrhage, DH decompresivehaemicraniectomy.